Today: 25 May 2026
Qualcomm stock slips as Mizuho trims target on weaker 2026 handset outlook
26 January 2026
1 min read

Qualcomm stock slips as Mizuho trims target on weaker 2026 handset outlook

New York, Jan 26, 2026, 15:45 EST — Regular session

  • Qualcomm shares dipped roughly 0.6% in afternoon trading, underperforming the stronger broader market
  • Mizuho lowers its price target to $160, citing weaker handset shipments in 2026
  • Attention shifts to the Fed decision set for Jan. 28, with Qualcomm’s earnings report due Feb. 4

Qualcomm shares slipped Monday following a price target cut from Mizuho, which highlighted a weaker forecast for global smartphone shipments this year. The stock dipped roughly 0.6% to $154.90 in afternoon trading.

The decline came amid an otherwise stable session for major U.S. tech stocks, as investors searched for fresh signals on demand and pricing trends. Qualcomm often acts as a barometer for the phone market, with expectations shifting rapidly ahead of its earnings report.

This week’s focus is sharpened by the Federal Reserve’s policy meeting wrapping up on Wednesday. Growth stocks, which are sensitive to interest rates, have been quick to move in response to changes in bond yields and Fed signals.

Mizuho’s Vijay Rakesh trimmed his price target on Qualcomm to $160 from $175, maintaining a Neutral rating. The move follows an industry call centered on handsets. He projects global handset shipments will drop roughly 4% year-on-year in 2026, citing rising memory costs and tighter supply as additional headwinds later in the year.

In a separate note from , Mizuho flagged possible production cuts among some Chinese phone makers. Apple and Samsung, meanwhile, appear better off when it comes to memory supply. The firm also noted Apple is gaining ground in China, boosted by buybacks and discounts timed for the Lunar New Year.

Mizuho highlighted rising competition at the high end from MediaTek for Qualcomm, alongside softer content from key customers. The firm also cautioned that Qualcomm remains heavily reliant on handsets, which make up most of its chip sales, leaving it vulnerable if upgrade cycles falter once more.

Chip stocks showed a mixed picture. The iShares Semiconductor ETF dropped roughly 0.4%, yet the S&P 500 and Nasdaq ETFs each climbed around 0.6%. Nvidia fell close to 0.7%, while Broadcom gained nearly 1.9%.

“Communications and technology sectors are performing strongly today ahead of earnings reports from many major companies,” Chris Zaccarelli, chief investment officer at Northlight Asset Management, told Reuters. Reuters

Still, the handset segment could pose a risk. Should memory costs remain high and unit sales drop beyond projections, Qualcomm might encounter harsher pricing pressures and see less flexibility in managing operating expenses, even if its non-handset divisions remain steady.

Investors have a key date coming up. Qualcomm plans to release its fiscal first-quarter earnings on Feb. 4, right after the market closes. The company will hold its earnings call at 1:45 p.m. Pacific.

Stock Market Today

  • Black Diamond Therapeutics Shares Drop 35.8% After Mixed Phase II NSCLC Trial Results
    May 25, 2026, 12:23 PM EDT. Black Diamond Therapeutics (BDTX) shares plunged 35.8% following a mixed update on its phase II trial of silevertinib, an investigational tyrosine kinase inhibitor (TKI) for first-line non-small cell lung cancer (NSCLC) patients with EGFR non-classical mutations. The study showed promising efficacy with a median progression-free survival (mPFS) of 15.2 months and strong central nervous system (CNS) activity. However, investor concerns lingered due to the small patient cohort, dose-related safety issues, and unclear regulatory path. Silevertinib demonstrated a 60% objective response rate and 91% disease control rate among 43 patients, including those with brain metastases. While the preliminary data hint at durable benefits, further follow-up is required to confirm these results, contributing to the volatile market reaction.

Latest articles

Wendy’s turnaround now extends beyond burger discounts

Wendy’s turnaround now extends beyond burger discounts

25 May 2026
Wendy’s U.S. same-restaurant sales fell 7.8% in Q1 after an 11.3% drop in Q4, prompting Zacks Research to lower its Q2 earnings forecast to 17 cents per share. Robert Wright took over as CEO on May 21 as the chain closed 164 U.S. stores and faces pressure from activist investor Nelson Peltz. Shares last traded at $7.81 before the Memorial Day market closure.
Shopify Holds in New York as AI Selloff Keeps Traders Focused

Shopify Holds in New York as AI Selloff Keeps Traders Focused

25 May 2026
Shopify closed at $103.00 on Nasdaq Friday, down 1.77%, before U.S. markets shut for Memorial Day. Toronto shares rose 1.16% to C$144.15 as Canadian markets stayed open. The stock is down 36% for the year despite a 2.71% gain over five days. Debate continues over AI-driven growth versus rising expenses after the company’s May earnings reset.
Keel Infrastructure Stock Is Jumping — Now Comes the AI Lease Test

Keel Infrastructure Stock Is Jumping — Now Comes the AI Lease Test

25 May 2026
Keel Infrastructure’s Toronto-listed shares rose 6.94% to CA$7.09 on Monday, while its Nasdaq line remained closed for Memorial Day after ending Friday at $4.81, up 3.66%. Investors are watching Keel’s pivot from bitcoin mining to leasing power-backed data centers for AI. First-quarter revenue fell 23% to $37 million, with a $128 million loss from continuing operations. Keel reported $533 million in liquidity.
Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play
Previous Story

Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play

Astera Labs stock slides late — what ALAB investors are watching before Feb. 10
Next Story

Astera Labs stock slides late — what ALAB investors are watching before Feb. 10

Go toTop